Valentina Giampaoli (Amedeo Lonardo)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 28

Top Topics

Insulin Resistance

Randomized Controlled Trial

Chronic Kidney Disease

Top Venues

International journal of molecular sciences

Advances in therapy

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Valentina Giampaoli, Ming-Hua Zheng
Does an Aspirin a Day Take the MASLD Away? Advances in therapy 41 (7) (2024)
Valentina Giampaoli, Ralf Weiskirchen
From Hypothalamic Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease: Physiology Meets the Clinics via Metabolomics. Metabolites 14 (8) (2024)
Valentina Giampaoli, Ralf Weiskirchen
From Hypothalamic Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease: Physiology Meets the Clinics via Metabolomics. Metabolites 14 (8) (2024)
Valentina Giampaoli, Stefano Ballestri, Alessandro Mantovani, Giovanni Targher, Fernando Bril
Endpoints in NASH Clinical Trials: Are We Blind in One Eye? Metabolites 14 (1) (2024)
Valentina Giampaoli
PRO-C3, liver fibrosis and CKD: The plot thickens. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Valentina Giampaoli, Ralf Weiskirchen
From Hypothalamic Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease: Physiology Meets the Clinics via Metabolomics. Metabolites 14 (8) (2024)
Valentina Giampaoli, Stefano Ballestri, Alessandro Mantovani, Giovanni Targher, Fernando Bril
Endpoints in NASH Clinical Trials: Are We Blind in One Eye? Metabolites 14 (1) (2024)
Valentina Giampaoli
PRO-C3, liver fibrosis and CKD: The plot thickens. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Valentina Giampaoli, Ming-Hua Zheng
Does an Aspirin a Day Take the MASLD Away? Advances in therapy (2024)
Valentina Giampaoli, Stefano Ballestri, Alessandro Mantovani, Giovanni Targher, Fernando Bril
Endpoints in NASH Clinical Trials: Are We Blind in One Eye? Metabolites 14 (1) (2024)
Norbert Stefan, Valentina Giampaoli, Giovanni Targher
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases. Nature reviews. Gastroenterology & hepatology (2023)
Valentina Giampaoli
The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management. A narrative review focusing on principal risk modifiers. Expert review of clinical pharmacology (2023)
Valentina Giampaoli, Ashwani K Singal, Natalia Osna, Kusum K Kharbanda
Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction. Metabolism and target organ damage 2 (3) (2022)
Valentina Giampaoli, Alessandro Mantovani, Salvatore Petta, Amedeo Carraro, Christopher D Byrne, Giovanni Targher
Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation. Nature reviews. Endocrinology 18 (10) (2022)
Valentina Giampaoli
Precision medicine in nonalcoholic fatty liver disease. Journal of gastroenterology and hepatology 37 (7) (2022)
Valentina Giampaoli
Metabolomic signature: one step forward in the process of obtaining NAFLD patients' metabolic identity card. The American journal of clinical nutrition 115 (3) (2022)
Valentina Giampaoli, Alessandro Mantovani, Giovanni Targher, Gyorgy Baffy
Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications. International journal of molecular sciences 23 (21) (2022)
Valentina Giampaoli, Juan Pablo Arab, Marco Arrese
Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management. Advances in therapy 38 (5) (2021)
Valentina Giampaoli
Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition? Journal of clinical medicine 10 (3) (2021)
Stefano Ballestri, Alessandro Mantovani, Enrica Baldelli, Simonetta Lugari, Mauro Maurantonio, Fabio Nascimbeni, Alessandra Marrazzo, Dante Romagnoli, Giovanni Targher, Valentina Giampaoli
Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. Diagnostics (Basel, Switzerland) 11 (1) (2021)
Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, Alessandro Csermely, Valentina Giampaoli, Giovanni Targher
Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials. Metabolites 11 (2) (2021)
Valentina Giampaoli, Simona Leoni, Khalid A Alswat, Yasser Mahrous Fouad
History of Nonalcoholic Fatty Liver Disease. International journal of molecular sciences 21 (16) (2020)
Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, Alessandro Csermely, Valentina Giampaoli, Jörn M Schattenberg, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut 71 (1) (2020)
Valentina Giampaoli, Simonetta Lugari, Fabio Nascimbeni
Telomere shortening: An innocent bystander at the crossroad of NASH with ageing and cardiometabolic risk? Liver international : official journal of the International Association for the Study of the Liver 38 (10) (2019)
Valentina Giampaoli, Alessandro Mantovani, Simonetta Lugari, Giovanni Targher
NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management. International journal of molecular sciences 20 (11) (2019)
Valentina Giampaoli, Simonetta Lugari, Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Mauro Maurantonio
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? Acta diabetologica 56 (4) (2018)
Fabio Nascimbeni, Dante Romagnoli, Stefano Ballestri, Enrica Baldelli, Simonetta Lugari, Valentina Sirotti, Valentina Giampaoli, Amedeo Lonardo
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? Diseases (Basel, Switzerland) 6 (1) (2018)
Valentina Giampaoli, Giovanni Targher
NAFLD: Is There Anything New under the Sun? International journal of molecular sciences 18 (9) (2017)